Pharmacy customers drawn to on-site beauty services
As many as 58% of consumers are likely to purchase beauty services — such as manicures or brow shaping — at a drug store on an independent visit or while waiting for a prescription to be filled, according to an online survey of almost 700 AccentHealth viewers conducted in April. And of those likely to use services, 55% indicated they would fill a prescription at a pharmacy that they wouldn’t typically use if not for the beauty services.
To see more Patient Views, click here
Patient Views is a new, exclusive consumer insights feature that appears in every edition of DSN magazine, as well as the daily e-newsletter DSN A.M. If you could ask 6,000 patients anything at all, what would it be? Send your questions to [email protected].
Source: AccentHealth. To view the demographic breakdown of participants, click here.
Nonprofit honors Walgreens with Best Employers for Healthy Lifestyles award
WASHINGTON — The National Business Group on Health, a nonprofit association of large U.S. employers, today honored Walgreens for its ongoing commitment and dedication to promoting a healthy workplace and encouraging their workers and families to pursue and maintain healthy lifestyles.
Walgreens was among 65 U.S. employers that received the 2013 "Best Employers for Healthy Lifestyles" award at the Leadership Summit sponsored by the National Business Group on Health’s Institute on Innovation in Workforce Well-being. Walgreens received a gold award for its “You and Walgreens.” This marks the first year Walgreens has received the award.
“You and Walgreens” provides 250,000 Walgreens team members and their families’ access to a variety of health and wellness resources such as free health testing, online health assessment, personal health coaches, online wellness programs, tobacco-free program, fitness center, on-site Healthy Living Centers, weight management programs and Work & Life Resources. Participants are also eligible to receive incentives through medical premium reduction and gift cards.
“For more than 111 years, Walgreens has been committed to helping its customers and team members get, stay and live well,” said Kathleen Wilson-Thompson, Walgreens senior vice president and chief human resources officer. “We recognize the importance of team member engagement by providing the tools and resources to keep our organization happy and healthy.”
Helen Darling, president and CEO of the National Business Group on Health, commented, “We are proud to honor Walgreens for its ongoing commitment to providing lifestyle improvement programs that encourage healthy lifestyles for their employees. Walgreens is among an elite group of organizations that are leading the way to promoting healthy workplaces and lifestyles. Walgreens and its management team should be proud of their commitment to their program and we congratulate them on receiving this award.”
Winners of the “Best Employers for Healthy Lifestyles” awards were honored in one of two categories: Platinum, for established healthy weight, healthy lifestyles programs with measurable success and documented outcomes; or Gold, for creating cultural and environmental changes that support employees who are committed to long-term behavior changes.
Par ships authorized generic cardiovascular drug
WOODCLIFF LAKE, N.J. — Generic drug maker Par Pharmaceutical Cos. has started shipping an authorized generic version of a heart-disease medication made by AstraZeneca.
Par said it had entered into an agreement with AstraZeneca to supply authorized generic Atacand (candesartan cilexetil) and had begun shipping the drug in the 4 mg, 8 mg, 16 mg and 32 mg strengths. Atacand has annual sales of about $113 million, according to IMS Health, and is used to treat certain kinds of heart failure and high blood pressure in children and adults.
Authorized generics are branded drugs marketed at a discount under their generic names, usually under a deal between the original manufacturer and a third-party company. Novartis generic subsidiary Sandoz announced Wednesday that it had received Food and Drug Administration approval for the generic version of Atacand.